Kate L. Iwamoto, M.D., is a pediatrician with Mercy Family Care Physicians in Downtown Baltimore.
Mercy doctors offer a breakthrough treatment for hepatitis C that cures most patients and saves lives. Hepatitis C is an infection of the liver caused by the hepatitis C virus and can lead to permanent liver damage if untreated.
Women’s Imaging at Mercy is a dedicated breast imaging and diagnostic Center. Our radiologists offer mammograms, ultrasound, biopsies and MRI to diagnose and treat breast diseases.
Mercy offers emergency care on the Downtown Baltimore campus 24 hours a day, 7 days a week (410-332-9477) with access to a trained emergency medicine team, diagnostic services and consultations with specialists.
In case of an Emergency, Dial 911 and follow the instructions of the EMS (Emergency Medical Services) team.
Mercy Medical Center's downtown campus includes our Main Hospital - The Mary Catherine Bunting Center, McAuley Plaza and The Weinberg Center.
General visiting hours at Mercy are 11:00 am to 8:30 pm. Hours vary by floor, please check with the nursing staff or call 410-332-9555.
Led by Dr. Paul Thuluvath, the Baltimore GI doctors and specialists of The Melissa L. Posner Institute for Digestive Health & Liver Disease at Mercy are among the best in the diagnosis and treatment of diseases of the digestive tract. With several renowned national and international authorities on staff, the Institute provides advanced diagnosis and leading edge treatment options for patients in a setting that is comfortable, collaborative and encouraging for patients and their families.
Dr. Scott Huber
Dr. Patrick Hyatt
Dr. Mary Harris, Medical Director
Dr. Jeffery Nelson, Surgical Director
Dr. Matilda Hagan
Dr. Paul Thuluvath, Director
Dr. Anurag Maheshwari
Dr. Hwan Yoo
Dr. Amit Raina, Director
Dr. Sergey Kantsevoy, Director
Dr. Michael Cox
Dr. Richard Desi
Dr. Lisa Pichney
The Institute for Digestive Health & Liver Disease at Mercy Medical Center brings Baltimore-based top gastroenterologists, doctors, surgeons and specialists to the patient communities of the Mid-Atlantic region with leading treatments for diseases and conditions affecting the digestive tract, including liver and hepatobiliary diseases, inflammatory bowel and colorectal diseases such as Crohn's disease or colitis, conditions of the pancreas, heartburn and reflux disease (GERD), and stomach and intestinal disorders.
Dr. Richard Desi of The Institute for Digestive Health and Liver Disease, focuses on hepatology, a sub-specialty of gastroenterology that addresses the liver, gallbladder, pancreas and biliary tract.
Smokers who quit have a 65 percent lower risk of a Crohn's disease flare-up and are less likely to need steroids or other medications.